Skip to main content
Log in

Combretastatin A4-based coumarins: synthesis, anticancer, oxidative stress-relieving, anti-inflammatory, biosafety, and in silico analysis

  • Original Paper
  • Published:
Chemical Papers Aims and scope Submit manuscript

Abstract

A potent natural combretastatin, combretastatin A-4 (COMA4) targets the condylon active pocket to produce anticancer effects. Studies on inflammation and oxidative stress have been linked to cancer, indicating that lowering these risk variables may have an adverse effect on the progression of cancer. This study utilized COMA4 as a building block to create 28 coumarins with improved therapeutic effects. The first coumarin derivative, COMA4-COU-1, was activated by thionyl chloride and then coupled with various phenols, resulting in 27 COMA4-COU derivatives. Biomedical-related activities were conducted using COMA4 as a reference, including anticancer activity assayed against eight cancerous cellular populations, antioxidant activity evaluated on H2O2-treated human SH-SY5Y populations, and anti-inflammatory activity tested against three enzymatic mediators of inflammation. The biosafety studies included testing the effects of COMA4 and its coumarins on the normal growth of three cell populations and on human erythrocyte hemolysis. Finally, the pharmacokinetic indexes of the building block and its derivatives were computerized using two web-based programs. The results indicated that the biomedical activities are directly improved by the presence of an electron-donating group on the off-side aromatic ring. Also, these activities were increased when this group substituted at the para or meta position. The maximum activities were revealed when this aromatic ring was trisubstituted with this group type, with privilege activities for the trimethoxy aromatic ring. Concerning the biocompatibility studies, the synthetic coumarins demonstrated a high level of compatibility with the tested normal cells and also with human erythrocytes. Moreover, the in silico analysis demonstrated the capacity of the synthetic coumarins to present potential drug candidates. The author concluded that the coumarin-structural modification can open the door for developing new, potent, and biosafe COMA4 derivatives. In this regard, this study afforded many insights about the structure–function relationships of the synthesized compounds that can guide future research about COMA4-based derivatives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Scheme 1

Similar content being viewed by others

Data availability

All the data used in this work are recorded.

References

Download references

Acknowledgements

The College of Pharmacy/University of Mosul is thanked by the author for supplying the resources needed to finish this work.

Funding

The article is funded by the author.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasser Fakri Mustafa.

Ethics declarations

Conflict of interest

There is no conflict of interest to declare.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

The author gives consent to the publication of the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 473 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mustafa, Y.F. Combretastatin A4-based coumarins: synthesis, anticancer, oxidative stress-relieving, anti-inflammatory, biosafety, and in silico analysis. Chem. Pap. 78, 3705–3720 (2024). https://doi.org/10.1007/s11696-024-03341-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11696-024-03341-5

Keywords

Navigation